Vertaling van "safety ●● collecting and evaluating " (Nederlands → Frans) :

serious adverse events associated with the collection, testing, processing, storage and distribution of blood or blood components that may have an effect on their quality or safety ●● Collecting and evaluating information about
serious adverse events associated with the collection, testing, processing, storage and distribution of blood or blood components that may have an effect on their quality or safety ●● Collecting and evaluating information about

The evaluation of oncological adverse effects (as well as the evaluation of the Periodic Safety Update Report – PSUR, Annual Safety Report - ASR, Suspected Unexpected Serious Adverse Reaction
The evaluation of oncological adverse effects (as well as the evaluation of the Periodic Safety Update Report – PSUR, Annual Safety Report - ASR, Suspected Unexpected Serious Adverse Reaction

Beschrijving Post-Authorisation Safety Study of Esbriet (Pirfenidone): A Prospective Observational Registry to Evaluate Long-Term Safety in a Real-World Setting.
Description Etude de sécurité après octroi de l’autorisation avec Esbriet (Pirfénidone) : Registre prospectif observationnel afin d’évaluer la sécurité à long terme en contexte de vie réel.

‐ The Mirasol Clinical Evaluation Study Group. A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology.
the performance and safety of platelets treated with MIRASOL pathogen reduction technology.

- [http ...]
- [http ...]

haemovigilance data and monitoring their implementation ●● The first annual report of the Haemovigilance Centre was published in 2007 Since November 2005, hospitals and blood establishments have been required to report to the Belgian Centre for Haemovigilance of the FAMHP serious reactions during the collection or administration of blood components and serious events relating to the quality or safety of blood components.
haemovigilance data and monitoring their implementation ●● The first annual report of the Haemovigilance Centre was published in 2007 Since November 2005, hospitals and blood establishments have been required to report to the Belgian Centre for Haemovigilance of the FAMHP serious reactions during the collection or administration of blood components and serious events relating to the quality or safety of blood components.

The evaluation is based on current standards and guidelines on the quality, safety and clinical efficacy of medicines and health products.
The evaluation is based on current standards and guidelines on the quality, safety and clinical efficacy of medicines and health products.

The “PRE pillar” is also responsible for the evaluation of the quality, safety and efficacy of the end products.
The “PRE pillar” is also responsible for the evaluation of the quality, safety and efficacy of the end products.

Include mental health in programmes dealing with occupational health and safety. iv. Assess the potential impact of any new policy on the mental well-being of the population before its introduction and evaluate its results afterwards.
Include mental health in programmes dealing with occupational health and safety.

Evaluation of safety devices for preventing percutaneous injuries among health-care workers during phlebotomy procedures — Minneapolis- St. Paul, New York City, and San Francisco, 1993-1995 MMWR 1997; 46:21-8.
Evaluation of safety devices for preventing percutaneous injuries among health-care workers during phlebotomy procedures — Minneapolis- St. Paul, New York City, and San Francisco, 1993-1995 MMWR 1997 ; 46:21-8.